Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores, G M
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. [electronic resource] - The Journal of pharmacology and experimental therapeutics May 1996 - 728-38 p. digital
Publication Type: Journal Article
0022-3565
Alzheimer Disease--drug therapy
Animals
Avoidance Learning--drug effects
Body Temperature--drug effects
Cholinesterase Inhibitors--pharmacology
Galantamine--analogs & derivatives
Humans
Male
Mice
Rats
Rats, Sprague-Dawley
Rats, Wistar
Scopolamine--pharmacology
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. [electronic resource] - The Journal of pharmacology and experimental therapeutics May 1996 - 728-38 p. digital
Publication Type: Journal Article
0022-3565
Alzheimer Disease--drug therapy
Animals
Avoidance Learning--drug effects
Body Temperature--drug effects
Cholinesterase Inhibitors--pharmacology
Galantamine--analogs & derivatives
Humans
Male
Mice
Rats
Rats, Sprague-Dawley
Rats, Wistar
Scopolamine--pharmacology